A method of manufacturing an implantable medical device including applying a composition to an implantable medical device, the composition including a polymer, an active agent and a solvent; allowing the solvent to evaporate to form a dry coating, the dry coating comprising less than about 2% residual fluid content (w/w); applying a fluid to the dry coating, the fluid being substantially free from any polymer; and allowing the fluid to evaporate from the coating.

 
Web www.patentalert.com

> Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

~ 00386